page 5 References

Erich Knop, 1 Nadja Knop, 1 Thomas Millar, 2 Hiroto Obata, 3 and David A. Sullivan 4,5

1. Duke-Elder S, Wybar KC. The Anatomy of the Visual System. London : Henry Kimpton; 1961:577.

2. Bron AJ, Tiffany JM, Gouveia SM, Yokoi N, Voon LW. Functional aspects of the tear film lipid layer. Exp Eye Res . 2004;78:347–360.

3. Korb DR , Henriquez AS. Meibomian gland dysfunction and contact lens intolerance. J Am Optom Assoc . 1980;51:243–251.

4. Foulks GN, Bron AJ. Meibomian gland dysfunction: a clinical scheme for description, diagnosis, classification, and grading. Ocul Surf . 2003;1:107–126.

5. Bron AJ, Tiffany JM. The contribution of meibomian disease to dry eye. Ocul Surf . 2004;2:149 –165.

6. Knop E, Knop N, Brewitt H, et al. [Meibomian glands, Part III: meibomian gland dysfunction (MGD)—plaidoyer for a discrete disease entity and as an important cause of dry eye]. Meibomdrüsen, Teil III: Meibomdrüsen Dysfunktionen (MGD)—Plädoyer für ein eigenständiges Krankheitsbild und wichtige Ursache für das Trockene Auge. Ophthalmologe . 2009;106:966–979.

7. Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol . 1996;40:343–367.

8. Sullivan DA, Sullivan BD, Evans JE, et al. Androgen deficiency: meibomian gland dysfunction, and evaporative dry eye. Ann N Y Acad Sci . 2002;966:211–222.

9. Heiligenhaus A, Koch JM, Kemper D, Kruse FE, Waubke TN. [Therapy in tear film deficiencies]. Therapie von Benetzungsstö rungen. Klin Monatsbl Augenheilkd . 1994;204:162–168.

10. Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmo l. 1995;113:1266–1270.

11. Horwath-Winter J, Berghold A, Schmut O, et al. Evaluation of the Clinical Course of Dry Eye Syndrome. Arch Ophthalmo l. 2003; 121:1364–1368.

12. Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology . 1993;100:347–351.

13. Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye . 1991;5:395–411.

14. Paranjpe DR , Foulks GN. Therapy for meibomian gland disease. Ophthalmol Clin North Am . 2003;16:37–42.

15. Knop E, Knop N, Brewitt H. [Dry eye disease as a complex dysregulation of the functional anatomy of the ocular surface. New impulses to understanding dry eye disease] Das trockene Auge als komplexe Fehlregulation der funktionellen Anatomie der Augenoberfläche. Neue Impulse zum Verständnis des trockenen Auges. Ophthalmologe . 2003;100:917–928.

16. Heinrich Meibom, the younger 1638 –1700 (doctor). 2010. Available at http://en wikipedia org/wiki/Heinrich_Meibom_ %28poet%29. Accessed March 25, 2010.

17. Heinrich Meibom, the elder 1555–1625 (poet). 2010. http://wikipedia.org/wiki/ Heinrich_Meibom_%28poet%29. Accessed March 25, 2010.

18. Heinrich Meibom, 1638–1700 (Nova et Vetera). BMJ . 1938:2: 232.

19. Meibom H. De Vasis Palpebrarum Novis Epistola Helmestadi: Typis & sumptibus. Helmstadt , Germany : Henningi Mulleri; 1666.

20. Bron AJ, Tripathi DM, Tripathi BJ. Wolff's Anatomy of the Eye and Orbit. London : Chapman & Hall Medical; 1997: 231.

21. Knop E, Knop N. Anatomical and developmental background of the meibomian gland. In: Tiffany JM, ed. Proceedings of the Meibom 2000 Workshop. Boca Raton , FL : CRC Press; 2000.

22. Virchow H. Mikroskopische Anatomie der äusseren Augenhaut und des Lidapparates. In: Saemisch T, ed. Graefe-Saemisch Handbuch der gesamten Augenheilkunde. Band 1, 1. Abteilung, Kapitel II. 2 ed. Leibzig: Verlag W. Engelmann; 1910:431.

23. Wolff E. Anatomy of the Eye and Orbit. London : Lewis and Co.; 1954.

Knop N, Knop E. [Meibomian glands, Part I: anatomy, embryology and histology of the meibomian glands]. Meibom-Drüsen, Teil I: Anatomie, Embryologie und Histologie der Meibom-Drüsen. Ophthalmologe . 2009;106:872–883.

25. Greiner JV, Glonek T, Korb DR , et al. Volume of the human and rabbit meibomian gland system. Adv Exp Med Biol . 1998;438: 339–343.

26. Mann I. The Development of the Human Eye. Cambridge UK : Cambridge University Press; 1928.

27. Barber AN. Embryology of the Human Eye. St. Louis : C. V. Mosby Co.;1955:193–195.

28. Andersen H, Ehlers N, Matthiessen ME. Histochemistry and development of the human eyelids. Acta Ophthalmol ( Copenh ). 1965;43:642–668.

29. Zhang H, Hara M, Seki K, Fukuda K, Nishida T. Eyelid fusion and epithelial differentiation at the ocular surface during mouse embryonic development. Jpn J Ophthalmol . 2005;49:195–204.

30. Knop E, Ludescher M, Knop N. Keratinisation status and cytokeratins of the Human Meibomian gland epithelium. Acta Ophthalmol . 2009;87:2232.

31. Straatsma BR. Cystic Degeneration of the Meibomian Glands. AMA Arch Ophthalmo l. 1959;61:918–927.

32. Jester JV, Nicolaides N, Smith RE. Meibomian gland studies: histologic and ultrastructural investigations. Invest Ophthalmol Vis Sci . 1981;20:537–547.

33. Nicolaides N, Kaitaranta JK, Rawdah TN, Macy JI, Boswell FM, Smith RE. Meibomian gland studies: comparison of steer and human lipids. Invest Ophthalmol Vis Sci . 1981;20:522–536.

34. Gorgas K, Völkl A. Peroxisomes in sebaceous glands. IV. Aggregates of tubular peroxisomes in the mouse Meibomian gland. Histochem J. 1984;16:1079–1098.

35. Sirigu P, Shen RL, Pinto dS. Human meibomian glands: the ultrastructure of acinar cells as viewed by thin section and freezefracture transmission electron microscopies. Invest Ophthalmol Vis Sci . 1992;33:2284–2292.

36. Olami Y, Zajicek G, Cogan M, Gnessin H, Pe'er J. Turnover and migration of meibomian gland cells in rats' eyelids. Ophthalmic Res. 2001;33:170–175.

37. Knop E, Knop N. [Meibomian glands. Part II: Physiology, characteristics, distribution and function of meibomian oil] Meibom- Drüsen Teil II: Physiologie, Eigenschaften, Verteilung und Funktion des Meibom- Ö ls. Ophthalmologe . 2009;106:884–892.

38. Kozak I, Bron AJ, Kucharova K, et al. Morphologic and volumetric studies of the meibomian glands in elderly human eyelids. Cornea . 2007;26:610–614.

39. Seifert P, Spitznas M. Immunocytochemical and ultrastructural evaluation of the distribution of nervous tissue and neuropeptides in the meibomian gland. Graefes Arch Clin Exp Ophthalmol . 1996;234:648–656.

40. Thiboutot D. Regulation of Human Sebaceous Glands. J Investig Dermatol . 2004;123:1–12.

41. Dougherty JM, McCulley JP. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci. 1986;27:486–491.

42. Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol . 1984;68:524–528.

43. Bron AJ, Tiffany JM. The meibomian glands and tear film lipids. Structure, function, and control. Adv Exp Med Biol . 1998;438: 281–295.

44. Chew CK, Hykin PG, Jansweijer C, Dikstein S, Tiffany JM, Bron AJ. The casual level of meibomian lipids in humans. Curr Eye Res . 1993;12:255–259.

45. Chew CK, Jansweijer C, Tiffany JM, Dikstein S, Bron AJ. An instrument for quantifying meibomian lipid on the lid margin: the meibometer. Curr Eye Res . 1993;12:247–254.

46. Linton RG, Curnow DH, Riley WJ. The meibomian glands: An investigation into the secretion and some aspects of the physiology. Br J Ophthalmol . 1961;45:718–723.

47. Josephson JE. Appearance of the preocular tear film lipid layer. Am J Optom Physiol Opt . 1983;60:883–887.

48. Korb DR, Baron DF, Herman JP, et al. Tear film lipid layer thickness as a function of blinking. Cornea . 1994;13:354–359.

Yokoi N, Mossa F, Tiffany JM, Bron AJ. Assessment of meibomian gland function in dry eye using meibometry. Arch Ophthalmo l. 1999;117:723–729.

50. Norn M. Expressibility of meibomian secretion: relation to age, lipid precorneal film, scales, foam, hair and pigmentation. Acta Ophthalmol ( Copenh ). 1987;65:137–142.

51. Korb DR, Blackie CA. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea . 2008;27:1142–1147.

52. Norn M. Meibomian orifices and Marx's line; studied by triple vital staining. Acta Ophthalmol ( Copenh ). 1985;63:698–700.

53. Arita R, Itoh K, Inoue K, Amano S. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology . 2008;115:911–915.

54. Blackie CA, Korb DR. Recovery time of an optimally secreting meibomian gland . Cornea. 2009;28:293–297.

55. Blackie CA, Korb DR . The diurnal secretory characteristics of individual meibomian glands . Cornea. 2010;29:34 –38.

56. Perra MT, Serra A, Sirigu P, Turno F. Histochemical demonstration of acetylcholinesterase activity in human Meibomian glands. Eur J Histochem . 1996;40:39–44.

57. Luhtala J, Palkama A, Uusitalo H. Calcitonin gene-related peptide immunoreactive nerve fibers in the rat conjunctiva. Invest Ophthalmol Vis Sci . 1991;32:640–645.

58. Hartschuh W, Weihe E, Reinecke M. Peptidergic (neurotensin, VIP, substance P) nerve fibres in the skin: immunohistochemical evidence of an involvement of neuropeptides in nociception, pruritus and inflammation. Br J Dermatol . 1983;109(suppl 25): 14–7:14 –17.

59. LeDoux MS, Zhou Q, Murphy RB, Greene ML, Ryan P. Parasympathetic innervation of the meibomian glands in rats. Invest Ophthalmol Vis Sci . 2001;42:2434–2441.

60. Diebold Y, Rios JD, Hodges RR, Rawe I, Dartt DA. Presence of nerves and their receptors in mouse and human conjunctival goblet cells. Invest Ophthalmol Vis Sci . 2001;42:2270–2282.

61. Stern ME, Gao J, Siemasko KF, Beuerman RW, Pflugfelder SC. The role of the lacrimal functional unit in the pathophysiology of dry eye. Exp Eye Res . 2004;78:409–416.

62. Stern ME, Beuerman RW, Fox RI, Gao J, Mircheff AK, Pflugfelder SC. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands . Cornea. 1998;17:584–589.

63. Alibardi L. Structural and immunocytochemical characterization of keratinization in vertebrate epidermis and epidermal derivatives. In: Kwang WJ, ed. International Review of Cytology A Survey of Cell Biology. Vol. 253. Academic Press; 2006:177–259.

64. Candi E, Schmidt R, Melino G. The cornified envelope: a model of cell death in the skin. Nat Rev Mol Cell Biol . 2005;6:328 –340.

65. Dartt DA. Signal transduction and control of lacrimal gland protein secretion: a review. Curr Eye Res . 1989;8:619–636.

66. Wolff E. The Anatomy of Eye and Orbit. London : Lewis 1954: 231.

67. Fuchs E. Skin stem cells: rising to the surface. J Cell Biol . 2008; 180:273–284.

68. Taylor G, Lehrer MS, Jensen PJ, Sun TT, Lavker RM. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell . 2000;102:451–461.

69. Pellegrini G, Golisano O, Paterna P, et al. Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface. J Cell Biol. 1999;145:769–782.

70. Kruse FE. Stem cells and corneal epithelial regeneration . Eye . 1994;8:170 –183.

71. Dua HS, Azuara -Blanco A. Limbal stem cells of the corneal epithelium. Surv Ophthalmol . 2000;44:415–425.

72. Pellegrini G, Bondanza S, Guerra L, De Luca M. Cultivation of human keratinocyte stem cells: current and future clinical applications. Med Biol Eng Comput. 1998;36:778–790.

73. Quesenberry PJ, Ramshaw H, Crittenden RB, et al. Engraftment of normal murine marrow into nonmyeloablated host mice. Blood Cells . 1994;20:348–350.

74. Ghazizadeh S, Taichman LB. Multiple classes of stem cells in cutaneous epithelium: a lineage analysis of adult mouse skin. EMBO J . 2001;20:1215–1222.

Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell . 1990;61: 1329–1337.

76. Richards SM, Yamagami H, Schirra F, Suzuki T, Jensen RV, Sullivan DA. Sex-related effect on gene expression in the mouse meibomian gland. Curr Eye Res . 2006;31:119–128.

77. Schirra F, Richards SM, Liu M, Suzuki T, Yamagami H, Sullivan DA. Androgen regulation of lipogenic pathways in the mouse meibomian gland. Exp Eye Res . 2006;83:291–296.

78. Schirra F, Suzuki T, Dickinson DP, Townsend DJ, Gipson IK, Sullivan DA. Identification of steroidogenic enzyme mRNAs in the human lacrimal gland, meibomian gland, cornea, and conjunctiva . Cornea. 2006;25:438–442.

79. Suzuki T, Schirra F, Richards SM, et al. Estrogen's and progesterone's impact on gene expression in the mouse lacrimal gland. Invest Ophthalmol Vis Sci . 2006;47:158–168.

80. Richards SM, Liu M, Jensen RV, et al. Androgen regulation of gene expression in the mouse lacrimal gland. J Steroid Biochem Mol Biol. 2005;96:401–413.

81. Schirra F, Suzuki T, Richards SM, et al. Androgen control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci . 2005;46:3666–3675.

82. Horsley V, O'Carroll D, Tooze R, et al. Blimp1 defines a progenitor population that governs cellular input to the sebaceous gland. Cell . 2006;126:597–609.

83. Fuchs E. Scratching the surface of skin development . Nature . 2007;445:834–842.

84. Morris RJ, Liu Y, Marles L, et al. Capturing and profiling adult hair follicle stem cells. Nat Biotech . 2004;22:411–417.

85. Oshima H, Rochat A, Kedzia C, Kobayashi K, Barrandon Y. Morphogenesis and renewal of hair follicles from adult multipotent stem cells . Cell. 2001;104:233–245.

86. Lo CC, Berta MA, Braun KM, et al. Characterization of bipotential epidermal progenitors derived from human sebaceous gland: contrasting roles of c-Myc and beta-catenin. Stem Cells . 2008;26: 1241–1252.

87. Nien CJ, Paugh JR, Massei S, Wahlert AJ, Kao WW, Jester JV. Age-related changes in the meibomian gland. Exp Eye Res . 2009; 89:1021–1027.

88. Blanpain C, Fuchs E. Epidermal homeostasis: a balancing act of stem cells in the skin. Nat Rev Mol Cell Biol . 2009;10:207–217.

89. Sellheyer K, Krahl D. Blimp-1: a marker of terminal differentiation but not of sebocytic progenitor cells (review). J Cutan Pathol. 2010;37:624–634.

90. Fuchs E, Horsley V. More than one way to skin. Genes Dev . 2008;22:976–985.

91. Allen M, Grachtchouk M, Sheng H, et al. Hedgehog signaling regulates sebaceous gland development. Am J Pathol . 2003;163: 2173–2178.

92. Niemann C, Unden AB, Lyle S, Zouboulis C, Toftgard R, Watt FM. Indian hedgehog and beta-catenin signaling: role in the sebaceous lineage of normal and neoplastic mammalian epidermis. Proc Natl Acad Sci U S A . 2003;100(Suppl 1):11873–11880.

93. Mao-Qiang M, Fowler AJ, Schmuth M, et al. Peroxisome-proliferator-activated receptor (PPAR)-[gamma] activation stimulates keratinocyte differentiation. J Investig Dermatol . 2004;123:305–312.

94. Tontonoz P, Spiegelman BM. Fat and beyond : the diverse biology of PPARgamma. Annu Rev Biochem . 2008;77:289–312.

95. Schoonjans K, Staels B, Auwerx J. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta . 1996;1302: 93–109.

96. Rosen ED, Sarraf P, Troy AE, et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell . 1999;4:611–617.

97. Rosenfield RL, Kentsis A, Deplewski D, Ciletti N. Rat Preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. J Investig Dermatol . 1999;112:226–232.

98. Trivedi NR, Cong Z, Nelson AM, et al. Peroxisome proliferatoractivated receptors increase human sebum production. J Investig Dermatol . 2006;126:2002–2009.

99. Rosenfield RL, Deplewski D, Kentsis A, Ciletti N. Mechanisms of androgen induction of sebocyte differentiation. Dermatology . 1998;196:43–46.

100. Heid HW, Moll R, Schwetlick I, Rackwitz HR, Keenan TW. Adipophilin is a specific marker of lipid accumulation in diverse cell types and diseases. Cell Tissue Res . 1998;294:309–321.

101. Gao J, Ye H, Serrero G. Stimulation of adipose differentiation related protein (ADRP) expression in adipocyte precursors by the fatty acids. J Cell Physiol . 2000;182:297–302.

102. Butovich IA, Millar TJ, Ham BM. Understanding and analyzing meibomian lipids (review). Curr Eye Res. 2008;33:405–420.

103. Butovich IA, Uchiyama E, McCulley JP. Lipids of human meibum: mass-spectrometric analysis and structural elucidation. J Lipid Res . 2007;48:2220–2235.

104. Tiffany JM. The lipid secretion of the meibomian glands. Adv Lipid Res . 1987;22:1– 62.

105. Sullivan BD, Evans JE, Dana MR, Sullivan DA. Influence of aging on the polar and neutral lipid profiles in human meibomian gland secretions. Arch Ophthalmo l. 2006;124:1286–1292.

106. Kutsuna M, Kodama T, Sumida M, et al. Presence of adipose differentiation-related protein in rat meibomian gland cells. Exp Eye Res . 2007;84:687–693.

107. Kurokawa I, Danby FW, Ju Q, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol . 2009;18:821–832.

108. Buitrago W, Joseph AK. Sebaceous carcinoma: the great masquerader: emgerging concepts in diagnosis and treatment. Dermatol Ther . 2008;21:459–466.

109. Keith CG. Seborrheic blepharo-kerato-conjunctivitis. Trans Ophthalmol Soc UK . 1967;87:85–103.

110. Cowper HW. Meibomian seborrhea. Am J Ophthalmol. 1922;5: 25–30.

111. Shields JA, Demirci H, Marr BP, Eagle RC Jr, Shields CL. Sebaceous carcinoma of the eyelids: personal experience with 60 cases. Ophthalmology. 2004;111:2151–2157.

112. Bull JJ, Pelengaris S, Hendrix S, Chronnell CM, Khan M, Philpott MP. Ectopic expression of c-Myc in the skin affects the hair growth cycle and causes an enlargement of the sebaceous gland. Br J Dermatol . 2005;152:1125–1133.

113. Lin Y, Wong Kk, Calame K. Repression of c-myc Transcription by Blimp-1, an inducer of terminal B cell differentiation. Science . 1997;276:596–599.

114. Ohinata Y, Payer B, O'Carroll D, et al. Blimp1 is a critical determinant of the germ cell lineage in mice. Nature . 2005;436:207– 213.

115. Saitou M, Payer B, O'Carroll D, Ohinata Y, Surani MA. Blimp1 and the emergence of the germ line during development in the mouse. Cell Cycle . 2005;4:1736–1740.

116. Harvey DJ, Tiffany JM, Duerden JM, Pandher KS , Mengher LS. Identification by combined gas chromatography-mass spectrometry of constituent long chain fatty acids and alcohols from the meibomian glands of the rat and a comparison with human meibomian lipids. J Chromatogr . 1987;414:253–263.

117. Schirra F, Richards SM, Sullivan DA. Androgen influence on cholesterogenic enzyme mRNA levels in the mouse meibomian gland. Curr Eye Res . 2007;32:393–398.

118. Van Haeringen NJ, Glasius E. Cholesterol in human tear fluid. Exp Eye Res . 1975;20:271–274.

119. Macsai MS. The role of omega-3 dietary supplementation in blepharitis and meibomian gland dysfunction (an AOS thesis). Trans Am Ophthalmol Soc. 2008;106:336–356.

120. Sullivan BD, Cermak JM, Sullivan RM, et al. Correlations between nutrient intake and the polar lipid profiles of meibomian gland secretions in women with Sjogren's syndrome. Adv Exp Med Biol . 2002;506:441–447.

121. Anderson GH, Kolattukudy PY. Fatty acid chain elongation by microsomal enzymes from the bovine meibomian gland. Arch Biochem Biophys 1984;237:177–185.

122. Butovich IA, Wojtowicz JC, Molai M. Human tear film and meibum. Very long chain wax esters and (O-acyl)-omega-hydroxy fatty acids of meibum. J Lipid Res . 2009;50:2471–2485.

Spychalla J, Kinney A, Browse J. Identification of an animal omega -3 fatty acid desaturase by heterologous expression in Arabidopsis. Proc Natl Acad Sci U S A. 1997;94:1142–1147.

124. Andrews JS. Human tear film lipids, I: composition of the principal non- polar component. Exp Eye Res . 1970;10:223–227.

125. Harvey DJ, Tiffany JM. Identification of meibomian gland lipids by gas chromatography- mass spectrometry: application to the meibomian lipids of the mouse. J Chromatogr . 1984;301:173–187.

126. Duerden JM, Tiffany JM. Lipid synthesis in vitro by rabbit meibomian gland tissue and its inhibition by tetracycline. Biochim Biophys Acta . 1990;1042:13–18.

127. Bishop JE, Hajra AK . Mechanism and specificity of formation of long chain alcohols by developing rat brain. J Biol Chem . 1981; 256:9542–9550.

128. Bishop JE, Hajra AK . Specificity of reduction of fatty acids to long chain alcohols by rat brain microsomes. J Neurochem . 1978;30: 643–647.

129. Perra MT, Lantini MS, Serra A, Cossu M, De Martini G, Sirigu P. Human meibomian glands: a histochemical study for androgen metabolic enzymes. Invest Ophthalmol Vis Sci . 1990;31:771–775.

130. Baillie AH, Thomson J, Milne JA. The distribution of hydroxysteroid dehydrogenase in human sebaceous glands. Br J Dermatol . 1966;78:451–457.

131. Baillie AH, Calman KC, Milne JA. Histochemical distribution of hydroxysteroid dehydrogenases in human skin. Br J Dermatol . 1965;77:610–616.

132. Butovich IA. Cholesteryl esters as a depot for very long chain fatty acids in human meibum. J Lipid Res . 2009;50:501–513.

133. Hausman GJ, Richardson RL. Cellular and vascular development in immature rat adipose tissue. J Lipid Res . 1983;24:522–532.

134. Tsai PS, Evans JE, Green KM, et al. Proteomic analysis of human meibomian gland secretions. Br J Ophthalmol . 2006;90:372–377.

135. Sullivan DA, Jensen RV, Suzuki T, Richards SM. Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands? Mol Vis . 2009;15:1553–1572.

136. Borchman D, Foulks GN, Yappert MC, Ho DV. Temperatureinduced conformational changes in human tearlipids hydrocarbon chains. Biopolymers . 2007;87:124–133.

137. Tiffany JM, Dart JKG. Normal and abnormal functions of meibomian secretion . R Soc Med Int Congr Symp Ser . 1981;40:1061–1064.

138. Kaercher T, Mobius D, Welt R. Biophysical behaviour of the infant Meibomian lipid layer. Int Ophthalmol . 1994;18:15–19.

139. Kaercher T, Honig D, Mobius D. Brewster angle microscopy. A new method of visualizing the spreading of Meibomian lipids. Int Ophthalmol . 1993;17:341–348.

140. Kaercher T, Mobius D, Welt R. Biophysical characteristics of the Meibomian lipid layer under in vitro conditions. Int Ophthalmol . 1992;16:167–176.

141. Leiske DL, Raju SR, Ketelson HA, Millar TJ, Fuller GG. The interfacial viscoelastic properties and structures of human and animal meibomian lipids. Exp Eye Res . 2010;90(5):598–604

142. Tiffany JM. Refractive index of meibomian and other lipids. Curr Eye Res . 1986;5:887–889.

143. Franck C. Fatty layer of the precorneal film in the ‘office eye syndrome'. Acta Ophthalmol Copenh . 1991;69:737–743.

144. Holly FJ. Formation and rupture of the tear film. Exp Eye Res . 1973;15:515–525.

145. Thody AJ, Shuster S. Control and function of sebaceous glands. Physiol Rev . 1989;69:383–416.

146. Thody AJ, Shuster S. Control of sebaceous gland function in the rat by alpha-melanocyte-stimulating hormone. J Endocrinol . 1975;64:503–510.

147. Deplewski D, Rosenfield RL. Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology . 1999;140:4089–4094.

148. Zouboulis CC, Xia L, Akamatsu H, et al. The human sebocyte culture model provides new insights into development and management of seborrhoea and acne. Dermatology . 1998;196:21–31.

149. Boudou P, Soliman H, Chivot M, et al. Effect of oral isotretinoin treatment on skin androgen receptor levels in male acneic patients. J Clin Endocrinol Metab . 1995;80:1158–1161.

150. Chen W, Kelly MA, Opitz-Araya X, Thomas RE, Low MJ, Cone RD. Exocrine gland dysfunction in MC5-R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides . Cell. 1997;91:789–798.

151. Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol . 2004;22:360–366.

152. Cabeza M, Miranda R, Arias E, Diaz de Leon L. Inhibitory effect of propranolol on lipid synthesis in gonadectomized male hamster flank organs. Arch Med Res . 1998;29:291–295.

153. Zouboulis CC, Bohm M. Neuroendocrine regulation of sebocytes: a pathogenetic link between stress and acne. Exp Dermatol . 2004;13(suppl 4):31–35.

154. Zouboulis CC, Seltmann H, Hiroi N, et al. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A . 2002;99:7148–7153.

155. Zhang L, Anthonavage M, Huang Q, Li WH, Eisinger M. Proopio-melanocortin peptides and sebogenesis. Ann N Y Acad Sci . 2003; 994:154–161.

156. Downie MM, Guy R, Kealey T. Advances in sebaceous gland research: potential new approaches to acne management. Int J Cosmet Sci . 2004;26:291–311.

157. Aisa J, Lahoz M, Serrano P, et al. Acetylcholinesterase-positive and paraformaldehyde-induced-fluorescence-positive innervation in the upper eyelid of the sheep (Ovis aries). Histol Histopathol . 2001;16:487–496.

158. Chanthaphavong RS, Murphy SM, Anderson CR. Chemical coding of sympathetic neurons controlling the tarsal muscle of the rat. Auton Neur osci. 2003;105:77–89.

159. Chung CW, Tigges M, Stone RA. Peptidergic innervation of the primate meibomian gland. Invest Ophthalmol Vis Sci . 1996;37: 238–245.

160. Fan Q, Smith PG. Decreased vasoactive intestinal polypeptide-
immunoreactivity of parasympathetic neurons and target innervation following long-term sympathectomy. Regul Pept . 1993;48: 337–343.

161. Hartschuh W, Reinecke M, Weihe E, Yanaihara N. VIP-immuno-
reactivity in the skin of various mammals: immunohistochemical, radioimmunological and experimental evidence for a dual localization in cutaneous nerves and merkel cells. Peptides . 1984;5: 239–245.

162. Horwath-Winter J, Flogel I, Ramschak-Schwarzer S, Hofer A, Kroisel PM. Psoriasis and hypogonadism in chronic blepharokeratocon-
junctivitis: a case report (in German). Ophthalmologe . 2002;99: 380–383.

163. Kirch W, Horneber M, Tamm ER. Characterization of Meibomian gland innervation in the cynomolgus monkey (Macaca fascicularis). Anat Embryol ( Berl ). 1996;193:365–375.

164. Lorber M. Somatostatin-like immunoreactivity (SLIR) in rat hard-erian and meibomian glands and glands of Zeis. Adv Exp Med Biol . 2002;506:81–89.

165. Luhtala J, Uusitalo H. The distribution and origin of substance P immunoreactive nerve fibres in the rat conjunctiva. Exp Eye Res . 1991;53:641–646.

166. Montagna W, Ellis RA. Cholinergic innervation of the Meibomian glands. Anat Rec. 1959;135:121–127.

167. Simons E, Smith PG. Sensory and autonomic innervation of the rat eyelid: Neuronal origins and peptide phenotypes. J Chem Neuroanat . 1994;7:35– 47.

168. Smith PG, Reddy H. Reorganization of cranial sympathetic pathways following neonatal ganglionectomy in the rat. J Comp Neurol. 1990;301:490–500.

169. Sokolov VE, Shabadash SA, Zelikina TI. Innervation of specific skin glands in the rabbit: the cholinergic terminal reticulum (in Russian). Dokl Akad Nauk SSSR. 1984;277:1245–1249.

170. Akamatsu H, Zouboulis CC, Orfanos CE. Control of human sebocyte proliferation in vitro by testosterone and 5-alpha-dihydrotestosterone is dependent on the localization of the sebaceous glands. J Investig Dermatol . 1992;99:509–511.

171. Choudhry R, Hodgins MB, van der Kwast TH, Brinkmann AO, Boersma WJ. Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J Endocrinol . 1992;133:467–475.

Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev . 2000;21:363–392.

173. Hall DW, Van den Hoven WE, Noordzij K, Jaitly KD. Hormonal control of hamster ear sebaceous gland lipogenesis. Arch Dermatol Res . 1983;275:1–7.

174. Hamilton JB. Male hormone substance: a prime factor in acne. J Clin Endocrinol Metab. 1941:570.

175. Imperato-McGinley J, Gautier T, Cai LQ, Yee B, Epstein J, Pochi P. The androgen control of sebum production. Studies of subjects with dihydrotestosterone deficiency and complete androgen insensitivity. J Clin Endocrinol Metab . 1993;76:524–528.

176. Ito A, Sakiguchi T, Kitamura K, Akamatsu H, Horio T. Establishment of a tissue culture system for hamster sebaceous gland cells. Dermatology . 1998;197:238–244.

177. Luderschmidt C, Eiermann W, Jawny J. Steroid hormone receptors and their relevance for sebum production in the sebaceous gland ear model of the Syrian hamster. Arch Dermatol Res . 1983;275:175–180.

178. Luu-The V, Sugimoto Y, Puy L, et al. Characterization, expression, and immunohistochemical localization of 5 alpha-reductase in human skin. J Investig Dermatol . 1994;102:221–226.

179. Miyake K, Ciletti N, Liao S, Rosenfield RL. Androgen receptor expression in the preputial gland and its sebocytes. J Investig Dermatol . 1994;103:721–725.

180. Pochi PE. Acne: endocrinologic aspects. Cutis . 1982;30:212–214, 216.

181. Pochi PE, Strauss JS. Endocrinologic control of the development and activity of the human sebaceous gland. J Investig Dermatol . 1974;62:191–201.

182. Puy LA, Turgeon C, Gagne D, et al. Localization and regulation of expression of the FAR-17A gene in the hamster flank organs. J Investig Dermatol . 1996;107:44–50.

183. Rony HR. Effect of androgen on the sebaceous glands of human skin. Arch Dermatol Syphilol . 1943:601–604.

184. Rosignoli C, Nicolas JC, Jomard A, Michel S. Involvement of the SREBP pathway in the mode of action of androgens in sebaceous glands in vivo. Exp Dermatol . 2003;12:480–489.

185. Stewart ME, Downing DT, Cook JS, Hansen JR, Strauss JS. Sebaceous gland activity and serum dehydroepiandrosterone sulfate levels in boys and girls. Arch Dermatol . 1992;128:1345–1348.

186. Strauss JS, Pochi PE . The human sebaceous gland: its regulation by steroidal hormones and its use as an end organ for assaying androgenicity in vivo. Recent Prog Horm Res. 1963;19:385–444.

187. Zouboulis CC, Akamatsu H, Stephanek K, Orfanos CE. Androgens affect the activity of human sebocytes in culture in a manner dependent on the localization of the sebaceous glands and their effect is antagonized by spironolactone. Skin Pharmacol. 1994; 7:33– 40.

188. Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Investig Dermatol . 1999;113:1011–1020.

189. Emanuel SV. Quantitative determinations of the sebaceous glands' function, with particular mention of the method employed. Acta Derm Venereol ( Stockh ). 1936:444–456.

190. Schroder HG, Ziegler M, Nickisch K, Kaufmann J, el Etreby MF. Effects of topically applied antiandrogenic compounds on sebaceous glands of hamster ears and flank organs. J Investig Dermatol . 1989;92:769–773.

191. Smith JG. Hormonal effects on aged human sebaceous glands. Acta Derm Venereol ( Stockh ). 1961:61–65.

192. Wirth H, Gloor M, Kimmel W. Influence of cyproterone acetate and estradiol on cell kinetics in the sebaceous gland of the golden hamster ear. Arch Dermatol Res . 1980;268:277–281.

193. Bologna JL. Aging skin. Am J Med. 1995:98(suppl 1A)99S–102S.

194. Labrie F. Extragonadal synthesis of sex steroids: intracrinology. Ann Endocrinol ( Paris ). 2003;64:95–107.

195. Labrie F. Adrenal androgens and intracrinology. Semin Reprod Med . 2004;22:299–309.

196. Labrie F, Belanger A, Simard J, Van LT, Labrie C. DHEA and peripheral androgen and estrogen formation: intracinology. Ann N Y Acad Sci . 1995;774:16–28.

197. Labrie F, Luu-The V, Belanger A, et al. Is dehydroepiandrosterone a hormone? J Endocrinol . 2005;187:169–196.

198. Sawaya ME, Penneys NS. Immunohistochemical distribution of aromatase and 3B-hydroxysteroid dehydrogenase in human hair follicle and sebaceous gland. J Cutan Pathol . 1992;19:309–314.

199. Thiboutot D, Gilliland K, Light J, Lookingbill D. Androgen metabolism in sebaceous glands from subjects with and without acne. Arch Dermatol . 1999;135:1041–1045.

200. Thiboutot D, Harris G, Iles V, Cimis G, Gilliland K, Hagari S. Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin. J Investig Dermatol . 1995;105:209–214.

201. Sullivan DA. Sex hormones and Sjogren's syndrome. J Rheumatol . 1997;24 Suppl 50:17–32.

202. Thiboutot D, Martin P, Volikos L, Gilliland K. Oxidative activity of the type 2 isozyme of 17beta-hydroxysteroid dehydrogenase (17beta-HSD) predominates in human sebaceous glands. J Investig Dermatol . 1998;111:390–395.

203. Thiboutot DM, Knaggs H, Gilliland K, Hagari S. Activity of type 1 5 alpha-reductase is greater in the follicular infrainfundibulum compared with the epidermis. Br J Dermatol . 1997;136:166–171.

204. Bain J. The many faces of testosterone. Clin Interv Aging . 2007; 2:567–576.

205. Cinci G, Pagani R, Pandolfi ML, Porcelli B, Pizzichini M, Marinello E. Effects of testosterone on cholesterol levels and fatty acid composition in the rat. Life Sci . 1993;53:91–97.

206. Gross SK, Lyerla TA, Evans JE, McCluer RH. Expression of glycosphingolipids in serum-free primary cultures of mouse kidney cells: male-female differences and androgen sensitivity. Mol Cell Biochem . 1994;137:25–31.

207. Hall RE, Birrell SN, Tilley WD, Sutherland RL. MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression. Eur J Cancer . 1994;30:484–490.

208. Ideta R, Seki T, Adachi K. Sequence analysis and characterization of FAR-17c, an androgen-dependent gene in the flank organs of hamsters. J Dermatol Sci . 1995;9:94 –102.

209. Marra CA, de Alaniz MJ. Regulatory effect of various steroid hormones on the incorporation and metabolism of [14C]stearate in rat hepatoma cells in culture. Mol Cell Biochem . 1995;145:1–9.

210. Mayes JS, Watson GH. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev . 2004;5:197–216.

211. Ojeda MS, Gomez N, Gimenez MS. Androgen regulation of lung lipids in the male rat. Lipids . 1997;32:57–62.

212. Saad F, Gooren L. The role of testosterone in the metabolic syndrome: a review. J Steroid Biochem Mol Biol . 2009;114: 40 – 43.

213. Seyama Y, Hida A, Hayashi S, Buzzell GR. Androgenic control of 1-alkyl-2,3-diacylglycerol in the harderian gland of the golden hamster, Mesocricetus auratus. J Biochem . 1996;119:799–804.

214. Swinnen JV, Esquenet M, Goossens K, Heyns W, Verhoeven G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res . 1997;57:1086–1090.

215. Swinnen JV, Heemers H, Heyns W, Verhoeven G. Androgen regulation of lipogenesis. Adv Exp Med Biol . 2002;506:379–387.

216. Swinnen JV, Ulrix W, Heyns W, Verhoeven G. Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci U S A . 1997;94:12975–12980.

217. Swinnen JV, Van Veldhoven PP, Esquenet M, Heyns W, Verhoeven G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology . 1996;137:4468 – 4474.

218. Swinnen JV, Verhoeven G. Androgens and the control of lipid metabolism in human prostate cancer cells. J Steroid Biochem Mol Biol . 1998;65:191–198.

219. Yamamoto A, Ito M. Sebaceous gland activity and urinary androgen levels in children. J Dermatol Sci . 1992;4:98 –104.

220. Heemers H, Vanderhoydonc F, Roskams T, et al. Androgens stimulate coordinated lipogenic gene expression in normal target tissues in vivo. Mol Cell Endocrinol . 2003;205:21–31.

221. Heemers HV, Verhoeven G, Swinnen JV. Androgen activation of the sterol regulatory element-binding protein pathway: current insights. Mol Endocrinol. 2006;20:2265–2277.

Steagall RJ, Yamagami H, Wickham LA, Sullivan DA. Androgen control of gene expression in the rabbit meibomian gland. Adv Exp Med Biol . 2002;506:465–476.

223. Sullivan DA, Sullivan BD, Ullman MD, et al. Androgen influence on the meibomian gland. Invest Ophthalmol Vis Sci . 2000;41: 3732–3742.

224. Yamagami H, Richards SM, Sullivan BD, Liu M, Steagall RJ, Sullivan DA. Gender-associated differences in gene expression of the meibomian gland. Adv Exp Med Biol . 2002;506:459–463.

225. Yamagami H, Schirra F, Liu M, Richards SM, Sullivan BD, Sullivan DA. Androgen influence on gene expression in the meibomian gland. Adv Exp Med Biol . 2002;506:477–481.

226. Clark JH. Mechanisms of action of steroid hormones. In: Wilson JD, ed. Williams Textbook of Endocrinology Philadelphia : WB Saunders;1992:35–90.

227. Lee HJ, Chang C. Recent advances in androgen receptor action. Cell Mol Life Sci. 2003;60:1613–1622.

228. Smithson G, Couse JF, Lubahn DB, Korach KS , Kincade PW. The role of estrogen receptors and androgen receptors in sex steroid regulation of B lymphopoiesis. J Immunol . 1998;161:27–34.

229. Rocha EM, Wickham LA, da Silveira LA, et al. Identification of androgen receptor protein and 5alpha-reductase mRNA in human ocular tissues. Br J Ophthalmol . 2000;84:76–84.

230. Wickham LA, Gao J, Toda I, Rocha EM, Ono M, Sullivan DA. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand . 2000;78:146–153.

231. Liu S, Khandelwal P, Hatton M, Sullivan DA. Culture, immortalization and characterization of human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci . 2010;51:3993–4005.

232. Voet DV. Biochemistry . 2 ed. New York : John Wiley & Sons, Inc.; 1995.

233. Swiss Institute of Bioinformatics: Universal Protein Resource Knowledgebase, http://www.expasy.uniprot.org/index.shtml. 2002. Accessed July 14, 2010.

234. Herrmann T, Buchkremer F, Gosch I, Hall AM, Bernlohr DA, Stremmel W. Mouse fatty acid transport protein 4 (FATP4): characterization of the gene and functional assessment as a very long chain acyl-CoA synthetase. Gene . 2001;270:31–40.

235. Tvrdik P, Westerberg R, Silve S, et al. Role of a new mammalian gene family in the biosynthesis of very long chain fatty acids and sphingolipids. J Cell Biol. 2000;149:707–718.

236. Karlsson M, Reue K, Xia YR, et al. Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Gene. 2001;272:11–18.

237. Lawn RM, Wade DP, Garvin MR, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest. 1999;104:R25–R31.

238. Santamarina-Fojo S, Remaley AT, Neufeld EB, Brewer HB Jr. Regulation and intracellular trafficking of the ABCA1 transporter. J Lipid Res . 2001;42:1339–1345.

239. Wang N, Silver DL, Thiele C, Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem . 2001;276:23742–23747.

240. Hettema EH, Tabak HF. Transport of fatty acids and metabolites across the peroxisomal membrane. Biochim Biophys Acta . 2000; 1486:18–27.

241. Sakakura Y, Shimano H, Sone H, et al. Sterol regulatory elementbinding proteins induce an entire pathway of cholesterol synthesis. Biochem Biophys Res Commun. 2001;286:176–183.

242. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest. 1997;99:846–854.

243. Shimano H, Yahagi N, Amemiya-Kudo M, et al. Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes. J Biol Chem . 1999; 274:35832–35839.

244. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res. 2001;40:439–452.

245. Labrie F, Luu-The V, Lin SX, et al. Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and disease. J Mol Endocrinol. 2000;25:1–16.

246. Asano K, Maruyama S, Usui T, Fujimoto N. Regulation of estrogen receptor alpha and beta expression by testosterone in the rat prostate gland. Endocr J. 2003;50:281–287.

247. Lindberg MK. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a “ying yang” relationship between ERalpha and ERbeta in mice. Mol Endocrinol. 2003;17: 203–208.

248. Stoeckelhuber M, Messmer EM, Schmidt C, Xiao F, Schubert C, Klug J. Immunohistochemical analysis of secretoglobin SCGB 2A1 expression in human ocular glands and tissues. Histochem Cell Biol. 2006;126:103–109.

249. Beato M, Klug J. Steroid hormone receptors: an update. Hum Reprod Update . 2000;6:225–236.

250. Kampa M, Pelekanou V, Castanas E. Membrane-initiated steroid action in breast and prostate cancer . Steroids . 2008;73:953–960.

251. Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab . 1997;82:2396–2402.

252. Lahita RG. The connective tissue diseases and the overall influence of gender. Int J Fertil Menopausal Stud. 1996;41:156–165.

253. Sullivan DA, Belanger A, Cermak JM, et al. Are women with Sjogren's syndrome androgen-deficient? J Rheumatol. 2003;30: 2413–2419.

254. Loy CJ, Yong EL. Sex, infertility and the molecular biology of the androgen receptor. Curr Opin Obstet Gynecol. 2001;13:315–321.

255. Brinkmann AO. Molecular basis of androgen insensitivity. Mol Cell Endocrinol. 2001;179:105–109.

256. Anderson J, Abrahamsson PA, Crawford D, Miller K, Tombal B. Management of advanced prostate cancer: can we improve on androgen deprivation therapy? BJU Int. 2008;101:1497–1501.

257. Cermak JM, Krenzer KL, Sullivan RM, Dana MR, Sullivan DA. Is complete androgen insensitivity syndrome associated with alterations in the meibomian gland and ocular surface? Cornea. 2003; 22:516–521.

258. Krenzer KL, Dana MR, Ullman MD, et al. Effect of androgen deficiency on the human meibomian gland and ocular surface. J Clin Endocrinol Metab . 2000;85:4874–4882.

259. Sullivan BD, Evans JE, Cermak JM, Krenzer KL, Dana MR, Sullivan DA. Complete androgen insensitivity syndrome: effect on human meibomian gland secretions. Arch Ophthalmo l. 2002;120:1689–1699.

260. Sullivan BD, Evans JE, Krenzer KL, Dana MR, Sullivan DA. Impact of antiandrogen treatment on the fatty acid profile of neutral lipids in human meibomian gland secretions. J Clin Endocrinol Metab . 2000;85:4866–4873.

261. Pflugfelder SC, Tseng SC, Sanabria O, et al. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation . Cornea. 1998;17:38 –56.

262. Physicians' Desk Reference. 53rd ed. Montvale , NJ : Medical Economics Co.; 1999.

263. Schaumberg DA, Dana R, Buring JE, Sullivan DA. Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmo l. 2009;127:763–768.

264. Sullivan BD, Evans JE, Dana MR, Sullivan DA. Impact of androgen deficiency on the lipid profiles in human meibomian gland secretions. Adv Exp Med Biol . 2002;506:449–458.

265. Tamer C, Oksuz H, Sogut S. Androgen status of the nonautoimmune dry eye subtypes. Ophthalmic Res. 2006;38:280–286.

266. Zeligs MA, Gordon K. Dehydroepiandrosterone Therapy for the Treatment of Dry Eye Disorders. International Patent Application WOL 94/04144, March, 1994.

267. Mamilis N. Dry eyes and testosterone deficiency in women. In: Abstracts of the Centennial Annual Meeting of the American Academy of Ophthalmology Chicago , IL : American Academy of Ophthalmology; 1996:132.

268. Belanger A. Determination of non-conjugated and conjugated steroids in human plasma. Proceedings of the Fifth Symposium on the Analysis of Steroids, Szombathely , Hungary , May 3–5, 1993. Budapest: Akademia Kiado: 1994;99–110.

269. Labrie F. Intracrinology. Mol Cell Endocrinol. 1991;78:C113–C118.

270. Labrie F, Diamond P, Cusan L, Gomez JL, Belanger A, Candas B. Effect of 12- month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J Clin Endocrinol Metab . 1997;82:3498–3505.

271. Labrie F, Belanger A, Cusan L, Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab . 1997;82:2403–2409.

272. Appelmans M. La Kerato -conjonctivite seche de Gougerot-Sjogren. Arch Ophtalmol. 1948;81:577–588.

273. Bizzarro A, Valentini G, Di Martino G, DaPonte A, De Bellis A, Iacono G. Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J Clin Endocrinol Metab . 1987;64:32–36.

274. Brückner R. Ü ber einen erfolgreich mit Perandren behandelten Fall von Sjögrenïschem Symptomenkomplex. Ophthalmologica. 1945;110:37–42.

275. Lagresa MNS. Inducers of tears: androgens and human gammaglobulin. Rev Cubana Oftalmol . 2000:35–43.

276. Radnot M, Nemeth B. [The effect of testosterone preparations on the lacrimal glands.]. Orv Hetil. 1954;95:580–581.

277. Radnot M, Nemeth B. Effect of testosterone preparation on the lacrymal glands (In: German). Ophthalmologica. 1955;129:376–380.

278. Worda C, Nepp J, Huber JC, Sator MO. Treatment of keratoconjunctivitis sicca with topical androgen. Maturitas. 2001;37:209–212.

279. Schafer G, Krause W. The effect of estradiol on the sebaceous gland of the hamster ear and its antagonism by tamoxifen. Arch Dermatol Res . 1985;277:230–234.

280. Sweeney TM, Szarnicki RJ, Strauss JS, Pochi PE . The effect of estrogen and androgen on the sebaceous gland turnover time. J Investig Dermatol . 1969;53:8 –10.

281. Strauss JS, Kligman AM, Pochi PE . The effect of androgens and estrogens on human sebaceous glands. J Investig Dermatol . 1962;39:139–155.

282. Sansone-Bazzano G, Reisner RM, Bazzano G. A possible mechanism of action of estrogen at the cellular level in a model sebaceous gland. J Investig Dermatol . 1972;59:299–304.

283. Azzi L, El Alfy M, Labrie F. Gender differences and effects of sex steroids and dehydroepiandrosterone on androgen and oestrogen alpha receptors in mouse sebaceous glands. Br J Dermatol . 2006;154:21–27.

284. Saihan EM, Burton JL. Sebaceous gland suppression in female acne patients by combined glucocorticoid-oestrogen therapy. Br J Dermatol . 1980;103:139–142.

285. Pochi PE , Strauss JS. Sebaceous gland inhibition from combined glucocorticoid-estrogen treatment. Arch Dermatol . 1976;112: 1108–1109.

286. Smith ES. Direct photomicroscopic evidence for rapid nuclear penetration of lysosomal products in steroid targets after estrogen in vivo. Endocrinology. 1971;88:A151.

287. Wiren KM. Androgens and bone growth: it's location, location, location. Curr Opin Pharmacol. 2005;5:626–632.

288. Esmaeli B, Harvey JT, Hewlett B. Immunohistochemical evidence for estrogen receptors in meibomian glands. Ophthalmology . 2000;107:180–184.

289. Auw -Haedrich C, Feltgen N. Estrogen receptor expression in meibomian glands and its correlation with age and dry-eye parameters. Graefes Arch Clin Exp Ophthalmol . 2003;241:705–709.

290. Suzuki T, Sullivan BD, Liu M, et al. Estrogen and progesterone effects on the morphology of the mouse meibomian gland. Adv Exp Med Biol . 2002;506:483–488.

291. Suzuki T, Schirra F, Richards SM, Jensen RV, Sullivan DA. Estrogen and progesterone control of gene expression in the mouse meibomian gland. Invest Ophthalmol Vis Sci . 2008;49:1797–1808.

292. Nokelainen P, Peltoketo H, Vihko R, Vihko P. Expression cloning of a novel estrogenic mouse 17 beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase (m17HSD7), previously described as a prolactin receptor-associated protein (PRAP) in rat. Mol Endocrinol. 1998;12:1048–1059.

293. Baez JM, Barbour SE, Cohen DE. Phosphatidylcholine transfer protein promotes apolipoprotein A-I-mediated lipid efflux in Chinese hamster ovary cells. J Biol Chem . 2002;277:6198–6206.

294. Soni KG, Lehner R, Metalnikov P, et al. Carboxylesterase 3 (EC 3.1.1.1) is a major adipocyte lipase. J Biol Chem . 2004;279: 40683–40689.

295. Furuyama N, Fujisawa Y. Regulation of collagenolytic cysteine protease synthesis by estrogen in osteoclasts. Steroids. 2000;65: 371–378.

296. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry eye syndrome. JAMA. 2001;286: 2114–2119.

297. PharMetrics. Prevalence and treatment of dry eye in a managed care population. Atlanta , GA : NDC Health Information Services; 2000.

298. Gurwood AS, Gurwood I, Gubman DT, Brzezicki LJ. Idiosyncratic ocular symptoms associated with the estradiol transdermal estrogen replacement patch system. Optom Vis Sci. 1995;72:29 –33.

299. Verbeck B. Ocular and metabolic findings in patients on oral contraceptives (in German). Klin Monbl Augenheilkd. 1973;162: 612–621.

300. Cabeza M, Miranda R. Stimulatory effect of progesterone and 5 beta-progesterone on lipid synthesis in hamster flank organs. Steroids . 1997;62:782–788.

301. Foreman MI, Devitt H, Clanachan I. Inhibition of dihydrotestosterone-mediated hamster sebaceous gland hypertrophy by progesterone. Br J Dermatol . 1984;110:185–186.

302. Girard J, Barbier A, Lafille C. Inhibition of testosterone metabolism and lipogenesis in animal sebaceous glands by progesterone. Arch Dermatol Res . 1980;269:281–290.

303. Matias JR, Malloy VL, Orentreich N. Synergistic antiandrogenic effects of topical combinations of 5 alpha-reductase and androgen receptor inhibitors in the hamster sebaceous glands. J Investig Dermatol . 1988;91:429–433.

304. Nuck BA, Fogelson SL, Lucky AW. Topical minoxidil does not act as an antiandrogen in the flank organ of the golden Syrian hamster. Arch Dermatol . 1987;123:59–61.

305. Hinks WM, Thody AJ, Shuster S. Proceedings: Effect of progesterone on sebaceous gland activity in the rat. J Endocrinol . 1975;64:48P–49P.

306. Pal P, Bhattacharyya SP. Influence of progesterone on the activity of sebaceous gland in rat. Indian J Dermatol. 1985;30:11–19.

307. van der Lely MA. The nature of the action of progesterone on the sebaceous gland of the rat. Dermatologica . 1966;133:452–455.

308. Zheng Y, Prouty SM, Harmon A, Sundberg JP, Stenn KS , Parimoo S. Scd3: a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin. Genomics . 2001;71:182–191.

309. Chia EM, Mitchell P, Rochtchina E, Lee AJ, Maroun R, Wang JJ. Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study. Clin Exp Ophthalmol. 2003;31:229–232.

310. Den S, Shimizu K, Ikeda T, Tsubota K, Shimmura S, Shimazaki J. Association between meibomian gland changes and aging, sex, or tear function . Cornea. 2006;25:651–655.

311. Lin PY, Tsai SY, Cheng CY, Liu JH, Chou P, Hsu WM. Prevalence of dry eye among an elderly Chinese population in Taiwan : the Shihpai Eye Study. Ophthalmology. 2003;110:1096–1101.

312. Schaumberg DA, Sullivan DA, Buring JE, Dana MR. Prevalence of dry eye syndrome among US women. Am J Ophthalmol . 2003; 136:318–326.

313. Soong HK, Martin NF, Wagoner MD, et al. Topical retinoid therapy for squamous metaplasia of various ocular surface disorders. A multicenter, placebo-controlled double-masked study. Ophthalmology . 1988;95:1442–1446.

314. Egger SF, Huber-Spitzy V, Bohler K, Scholda C. Isotretinoin administration in treatment of acne vulgaris. A prospective study of the kind and extent of ocular complications (in German). Ophthalmologe . 1995;92:17–20.

315. Guy R, Ridden C, Kealey T. The improved organ maintenance of the human sebaceous gland: modeling in vitro the effects of epidermal growth factor, androgens, estrogens, 13-cis retinoic acid, and phenol red. J Investig Dermatol . 1996;106:454–460.

316. Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology . 1998;196:140–147.

317. Sato T, Imai N, Akimoto N, Sakiguchi T, Kitamura K, Ito A. Epidermal growth factor and 1alpha,25-dihydroxyvitamin D3 suppress lipogenesis in hamster sebaceous gland cells in vitro. J Investig Dermatol . 2001;117:965–970.

318. Zouboulis CC, Korge B, Akamatsu H, et al. Effects of 13-cisretinoic acid, all-trans-retinoic acid, and acitretin on the proliferation, lipid synthesis and keratin expression of cultured human sebocytes in vitro. J Investig Dermatol . 1991;96:792–797.

319. Tsukada M, Schroder M, Roos TC, et al. 13-cis retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors. J Investig Dermatol . 2000;115:321–327.

320. Lambert RW, Smith RE. Pathogenesis of blepharoconjunctivitis complicating 13-cis-retinoic acid (isotretinoin) therapy in a laboratory model. Invest Ophthalmol Vis Sci . 1988;29:1559–1564.

321. Lambert RW, Smith RE. Effects of 13-cis-retinoic acid on the hamster meibomian gland. J Investig Dermatol . 1989;92:321–325.

322. Kremer I, Gaton DD, David M, Gaton E, Shapiro A. Toxic effects of systemic retinoids on meibomian glands. Ophthalmic Res. 1994;26:124–128.

323. Zouboulis CC. Isotretinoin revisited: pluripotent effects on human sebaceous gland cells. J Investig Dermatol . 2006;126:2154–2156.

324. Caffery BE, Josephson JE. Ocular side effects of isotretinoin therapy. J Am Optom Assoc. 1988;59:221–224.

325. Egger SF, Huber-Spitzy V, Bohler K, et al. Ocular side effects associated with 13-cis-retinoic acid therapy for acne vulgaris: clinical features, alterations of tearfilm and conjunctival flora. Acta Ophthalmol Scand . 1995;73:355–357.

326. Fraunfelder FT, LaBraico JM, Meyer SM. Adverse ocular reactions possibly associated with isotretinoin. Am J Ophthalmol . 1985; 100:534–537.

327. Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol . 2001;132:299–305.

328. Gross EG, Helfgott MA. Retinoids and the eye. Dermatol Clin. 1992;10:521–531.

329. Jaanus SD. Ocular side effects of selected systemic drugs. Optom Clin . 1992;2:73–96.

330. Mathers WD, Shields WJ, Sachdev MS, Petroll WM, Jester JV. Meibomian gland morphology and tear osmolarity: changes with Accutane therapy . Cornea. 1991;10:286–290.

331. Perry MD, McEvoy GK. Isotretinoin: new therapy for severe acne. Clin Pharm . 1983;2:12–19.

332. Bozkurt B, Irkec MT, Atakan N, Orhan M, Geyik PO. Lacrimal function and ocular complications in patients treated with systemic isotretinoin. Eur J Ophthalmol . 2002;12:173–176.

333. Denis P, Nordmann JP, Saiag P, Liotet S, Laroche L, Saraux H. Chronic blepharoconjunctivitis during a treatment with acitretin (Soriatane) (in French). J Fr Ophtalmol . 1993;16:191–194.

334. Ubels JL, Veenstra E, Ditlev J, Ingersoll K. Interactions of testosterone and all-trans retinoic acid in regulation of androgen receptor expression in rat lacrimal gland. Exp Eye Res . 2003;77:741–748.

335. Ubels JL, Wertz JT, Ingersoll KE, Jackson RS, Aupperlee MD. Down-regulation of androgen receptor expression and inhibition of lacrimal gland cell proliferation by retinoic acid. Exp Eye Res . 2002;75:561–571.

336. Karlsson T, Vahlquist A, Kedishvili N, Torma H. 13-cis-retinoic acid competitively inhibits 3 alpha-hydroxysteroid oxidation by retinol dehydrogenase RoDH-4: a mechanism for its anti-androgenic effects in sebaceous glands? Biochem Biophys Res Commun. 2003;303:273–278.

337. Maskin SL, Tseng SC. Clonal growth and differentiation of rabbit meibomian gland epithelium in serum-free culture: differential modulation by EGF and FGF. Invest Ophthalmol Vis Sci . 1992; 33:205–217.

338. Jester JV, Nicolaides N, Kiss-Palvolgyi I, Smith RE. Meibomian gland dysfunction, II: The role of keratinization in a rabbit model of MGD. Invest Ophthalmol Vis Sci . 1989;30:936–945.

339. Cermak JM, Papas AS, Sullivan RM, Dana MR, Sullivan DA. Nutrient intake in women with primary and secondary Sjogren's syndrome. Eur J Clin Nutr. 2003;57:328–334.

340. Shimazaki J, Goto E, Ono M, Shimmura S, Tsubota K. Meibomian gland dysfunction in patients with Sjogren syndrome. Ophthalmology . 1998;105:1485–1488.

341. Kenouch S, Lombes M, Delahaye F, Eugene E, Bonvalet JP, Farman N. Human skin as target for aldosterone: coexpression of mineralocorticoid receptors and 11 beta-hydroxysteroid dehydrogenase. J Clin Endocrinol Metab . 1994;79:1334–1341.

342. Millar TJ, Pearson ML. The effects of dietary and pharmacological manipulation on lipid production in the meibomian and harderian glands of the rabbit. Adv Exp Med Biol . 2002;506:431–440.

343. Mohammadpour M, Javadi MA, Karimian F. Limbal stem cell deficiency in the context of autoimmune polyendocrinopathy. Eur J Ophthalmol. 2006;16:870–872.

344. Bohm M, Luger TA. The pilosebaceous unit is part of the skin immune system. Dermatology . 1998;196:75–79.

345. De Andrade AD, Birnbaum J, Magalon C, et al. Fel d I levels in cat anal glands. Clin Exp Allergy. 1996;26:178–180.

346. Hornemann SS. Interleukin 1 alpha mRNA and protein are expressed in cultures of human sebocytes at steady-state and their levels are barely influenced by lipopolysaccharides. J Investig Dermatol . 1997;108:382.

347. Metze D, Jurecka W, Gebhart W, Schmidt J, Mainitz M, Niebauer G. Immunohistochemical demonstration of immunoglobulin A in human sebaceous and sweat glands. J Investig Dermatol . 1989; 92:13–17.

348. Hykin PG, Bron AJ. Age-related morphological changes in lid margin and meibomian gland anatomy . Cornea. 1992;11:334–342.

349. Schaumberg DA, Sullivan DA, Dana MR. Epidemiology of dry eye syndrome. Adv Exp Med Biol . 2002;506:989–998.

350. Kohno T, Ohnishi Y. Histopathology of chronic meibomian gland abnormalities in experimental PCB-poisoned monkeys (in Japanese). Fukuoka Igaku Zasshi. 1987;78:254–258.

351. Ohnishi Y, Kohno T, Ishibashi T, Shinoda Y. Macroscopic observation of the meibomian gland of the monkeys with experimental PCB intoxication (in Japanese). Fukuoka Igaku Zasshi. 1983;74: 240–245.

352. Dougherty JM, McCulley JP. Analysis of the free fatty acid component of meibomian secretions in chronic blepharitis. Invest Ophthalmol Vis Sci . 1986;27:52–56.

353. McCulley JP, Dougherty JM. Bacterial aspects of chronic blepharitis. Trans Ophthalmol Soc UK . 1986;105:314–318.

354. Jester JV, Rife L, Nii D, Luttrull JK, Wilson L, Smith RE. In vivo biomicroscopy and photography of meibomian glands in a rabbit model of meibomian gland dysfunction. Invest Ophthalmol Vis Sci . 1982;22:660–667.

355. Arita R, Itoh K, Inoue K, Kuchiba A, Yamaguchi T, Amano S. Contact lens wear is associated with decrease of meibomian glands. Ophthalmology. 2009;116:379–384.

356. Henriquez AS, Korb DR. Meibomian glands and contact lens wear. Br J Ophthalmol . 1981;65:108–111.

357. Gutgesell VJ, Stern GA , Hood CI. Histopathology of meibomian gland dysfunction. Am J Ophthalmol . 1982;94:383–387.

358. Obata H, Horiuchi H, Miyata K, Tsuru T, Machinami R. Histopathological study of the meibomian glands in 72 autopsy cases (in Japanese). Nippon Ganka Gakkai Zasshi. 1994;98:765–771.

359. Ong BL. Relation between contact lens wear and Meibomian gland dysfunction. Optom Vis Sci . 1996;73:208–210.

360. Hom MM, Martinson JR, Knapp LL, Paugh JR. Prevalence of Meibomian gland dysfunction. Optom Vis Sci . 1990;67:710–712.

361. Goto E, Endo K, Suzuki A, Fujikura Y, Matsumoto Y, Tsubota K. Tear evaporation dynamics in normal subjects and subjects with obstructive meibomian gland dysfunction. Invest Ophthalmol Vis Sci . 2003;44:533–539.

362. Mathers WD, Shields WJ, Sachdev MS, Petroll WM, Jester JV. Meibomian gland dysfunction in chronic blepharitis . Cornea. 1991;10:277–285.

363. Lambert R, Smith RE. Hyperkeratinization in a rabbit model of meibomian gland dysfunction. Am J Ophthalmol . 1988;105:703–705.

364. Nicolaides N, Santos EC, Smith RE, Jester JV. Meibomian gland dysfunction, III: meibomian gland lipids. Invest Ophthalmol Vis Sci . 1989;30:946–951.

Ohnishi Y, Kohno T. Polychlorinated biphenyls poisoning in monkey eye. Invest Ophthalmol Vis Sci . 1979;18:981–984.

366. Yagyu H, Kitamine T, Osuga J, et al. Absence of ACAT-1 attenuates atherosclerosis but causes dry eye and cutaneous xanthomatosis in mice with congenital hyperlipidemia. J Biol Chem . 2000; 275:21324–21330.

367. Cui CY, Smith JA, Schlessinger D, Chan CC. X-linked anhidrotic ectodermal dysplasia disruption yields a mouse model for ocular surface disease and resultant blindness. Am J Pathol . 2005;167: 89–95.

368. Thiboutot D, Sivarajah A, Gilliland K, Cong Z, Clawson G. The melanocortin 5 receptor is expressed in human sebaceous glands and rat preputial cells. J Investig Dermatol . 2000;115:614–619.

369. Kiguchi K, Bol D, Carbajal S, et al. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development. Oncogene. 2000;19:4243–4254.

370. Zouboulis CC, Boschnakow A. Chronological ageing and photoageing of the human sebaceous gland. Clin Exp Dermatol. 2001; 26:600–607.

371. Park YG, Hayasaka S, Takagishi Y, Inouye M, Okumoto M, Oda S. Histological characteristics of the pelage skin of rough fur mice (C3H/HeJ- ruf/ruf). Exp Anim . 2001;50:179–182.

372. Naito A, Yoshida H, Nishioka E, et al. TRAF6-deficient mice display hypohidrotic ectodermal dysplasia. Proc Natl Acad Sci U S A. 2002;99:8766–8771.

373. Miyazaki M, Man WC, Ntambi JM. Targeted disruption of stearoyl-CoA desaturase1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid. The Journal of Nutrition. 2001;131:2260–2268.

374. Jong MC, Gijbels MJ, Dahlmans VE, et al. Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest. 1998;101:145–152.

375. Hayashi Y, Liu CY, Jester JJ, et al. Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-alpha signaling. Dev Biol. 2005;277:222–234.

376. Majumder K, Shawlot W, Schuster G, Harrison W, Elder FF, Overbeek PA. YAC rescue of downless locus mutations in mice. Mamm Genome. 1998;9:863–868.

377. Jester JV, Rajagopalan S, Rodrigues M. Meibomian gland changes in the rhino (hrrhhrrh) mouse. Invest Ophthalmol Vis Sci . 1988; 29:1190–1194.

378. Chan CC, Gery I, Kohn LD, Nussenblatt RB, Mozes E, Singer DS. Periocular inflammation in mice with experimental systemic lupus erythematosus: a new experimental blepharitis and its modulation. J Immunol. 1995;154:4830–4835.

379. Cui CY, Durmowicz M, Ottolenghi C, et al. Inducible mEDA-A1 transgene mediates sebaceous gland hyperplasia and differential formation of two types of mouse hair follicles. Hum Mol Genet. 2003;12:2931–2940.

380. Plikus M, Wang WP, Liu J, Wang X, Jiang TX, Chuong CM. Morpho-regulation of ectodermal organs: integument pathology and phenotypic variations in K14-Noggin engineered mice through modulation of bone morphogenic protein pathway. Am J Pathol . 2004;164:1099–1114.

381. Cascallana JL, Bravo A, Donet E, et al. Ectoderm-targeted overexpression of the glucocorticoid receptor induces hypohidrotic ectodermal dysplasia. Endocrinology . 2005;146:2629–2638.

382. Huang J, Dattilo LK, Rajagopal R, et al. FGF-regulated BMP signaling is required for eyelid closure and to specify conjunctival epithelial cell fate. Development . 2009;136:1741–1750.

383. Yeh S, De Paiva CS, Hwang CS, et al. Spontaneous T cell mediated keratoconjunctivitis in Aire-deficient mice. Br J Ophthalmol . 2009;93:1260–1264.

384. Chang SH, Jobling S, Brennan K, Headon DJ. Enhanced Edar signalling has pleiotropic effects on craniofacial and cutaneous glands. PLoS One. 2009;4:e7591.

385. Ong BL, Hodson SA, Wigham T, Miller F, Larke JR. Evidence for keratin proteins in normal and abnormal human meibomian fluids. Curr Eye Res . 1991;10:1113–1119.

386. Kellum RE. Acne vulgaris: studies in pathogenesis—relative irritancy of free fatty acids from C2 to C16. Arch Dermatol . 1968; 97:722–726.

387. Obata H. Anatomy and histopathology of human Meibomian gland . Cornea. 2002;21(Suppl. 2):S70 –S74.

388. Mathers WD, Billborough M. Meibomian gland function and giant papillary conjunctivitis. Am J Ophthalmol . 1992;114:188–192.

389. Knop E, Knop N. Meibomian glands. Part IV: Functional interactions in the pathogenesis of meibomian gland Dysfunction (MGD)] Meibom-Drüsen Teil IV: Funktionelle Interaktionen in der Pathogenese der Dysfunktion (MGD) (in German). Ophthalmologe . 2009;106:980–987.

390. Obata H, Yamamoto S, Horiuchi H, Machinami R. Histopathologic study of human lacrimal gland. Statistical analysis with special reference to aging. Ophthalmology. 1995;102:678–686.

391. Proctor GB, Carpenter GH. Regulation of salivary gland function by autonomic nerves. Auton Neurosci . 2007;133:3–18.

392. Teymoortash A, Sommer F, Mandic R, et al. Intraglandular application of botulinum toxin leads to structural and functional changes in rat acinar cells. Br J Pharmacol. 2007;152:161–167.

393. Osailan SM, Proctor GB, McGurk M, Paterson KL. Intraoral duct ligation without inclusion of the parasympathetic nerve supply induces rat submandibular gland atrophy. Int J Exp Pathol. 2006; 87:41–48.

394. McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89:1173–1180.

395. Messmer EM, Torres SE, Mackert MI, Zapp DM, Kampik A. In vivo confocal microscopy in blepharitis (in German). Klin Monatsbl Augenheilkd . 2005;222:894–900.

396. Matsumoto Y, Shigeno Y, Sato E, et al. The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy. Graefes Arch Clin Exp Ophthalmol. 2009;247:821–829.

397. Luo L, Li DQ, Doshi A, Farley W, Corrales RM, Pflugfelder SC. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci . 2004;45:4293–4301.

398. Jackson WB. Blepharitis: current strategies for diagnosis and management. Can J Ophthalmol. 2008;43:170–179.

399. Aronowicz JD, Shine WE, Oral D, Vargas JM, McCulley JP. Short term oral minocycline treatment of meibomianitis. Br J Ophthalmol . 2006;90:856–860.

400. Souchier M, Joffre C, Gregoire S, et al. Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment. Br J Ophthalmol . 2008; 92:819–822.

401. English FP, Nutting WB. Demodicosis of ophthalmic concern. Am J Ophthalmol . 1981;91:362–372.

402. Coston TO. Demodex folliculorum blepharitis. Trans Am Ophthalmol Soc. 1967;65:361–392.

403. Czepita D, Kuzna-Grygiel W, Czepita M, Grobelny A. Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis. Ann Acad Med Stetin. 2007;53:63–67.

404. McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol . 1977;84:788–793.

405. Heiligenhaus A, Koch JM, Kruse FE, Schwarz C, Waubke TN. Diagnosis and differentiation of dry eye disorders (in German). Ophthalmologe . 1995;92:6 –11.

406. Sullivan DA, Yamagami H, Liu M, et al. Sex steroids, the meibomian gland and evaporative dry eye. Adv Exp Med Biol . 2002; 506:389–399.

407. McCulley JP, Shine WE. The lipid layer of tears: dependent on meibomian gland function. Exp Eye Res . 2004;78:361–365.

408. McCulley JP, Shine WE. Meibomian gland function and the tear lipid layer. Ocul Surf . 2003;1:97–106.

409. Gilbard JP, Gray KL, Rossi SR. A proposed mechanism for increased tear-film osmolarity in contact lens wearers. Am J Ophthalmol . 1986;102:505–507.

410. Gilbard JP, Farris RL. Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca. Arch Ophthalmo l. 1979;97:1642–1646.

411. Luo L, Li DQ, Corrales RM, Pflugfelder SC. Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface. Eye Contact Lens. 2005;31:186–193.

412. Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC. JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells. Exp Eye Res . 2006;82:588–596.

Mathers WD, Lane JA. Meibomian gland lipids, evaporation, and tear film stability. Adv Exp Med Biol . 1998;438:349–360.

414. Mathers W. Evaporation from the ocular surface. Exp Eye Res . 2004;78:389–394.

415. Pflugfelder SC. Tear fluid influence on the ocular surface. Adv Exp Med Biol . 1998;438:611–617.

416. Stern ME, Pflugfelder SC. Inflammation in dry eye. Ocul Surf . 2004;2:124 –130.

417. Dana MR, Hamrah P. Role of immunity and inflammation in corneal and ocular surface disease associated with dry eye. Adv Exp Med Biol . 2002;506:729–738.

418. Knop E, Knop N. Influence of the eye-associated lymphoid tissue (EALT) on inflammatory ocular surface disease. Ocul Surf . 2005; 3:S180 –S186.

419. Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients. Am J Ophthalmol . 2002;133: 181–186.

420. Brewitt H, Kaercher T, Rüfer F. [Dry eye and blepharitis.] Trockenes Auge und Blepharitis. Klin Monatsbl Augenheilkd . 2008;225:R15–R36.

421. Gilbard JP, Rossi SR, Gray KL. A new rabbit model for keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci . 1987;28:225–228.

422. McCann LC, Tomlinson A, Pearce EI, Diaper C. Tear and meibomian gland function in blepharitis and normals. Eye Contact Lens. 2009;35:203–208.

423. Afonso AA, Monroy D, Stern ME, Feuer WJ, Tseng SC , Pflugfelder SC. Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symptoms. Ophthalmology. 1999;106:803–810.

424. Robin JB, Jester JV, Nobe J, Nicolaides N, Smith RE. In vivo transillumination biomicroscopy and photography of meibomian gland dysfunction. a clinical study. Ophthalmology . 1985;92:1423–1426.

425. Yokoi N, Komuro A, Yamada H, Maruyama K, Kinoshita S. A newly developed video-meibography system featuring a newly designed probe. Jpn J Ophthalmol. 2007;51:53–56.

426. Nichols JJ, Berntsen DA, Mitchell GL, Nichols KK. An assessment of grading scales for meibography images . Cornea. 2005;24:382–388.

427. Knop E, Korb DR , Blackie CA , Knop N. The lid margin is an underestimated structure for preservation of ocular surface health and development of dry eye disease. In: Brewitt H, ed. Research Projects in Dry Eye. Basel , Switzerland : Karger; 2010:108–122.

428. Dana MR, Qian Y, Hamrah P. Twenty-five-year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection . Cornea. 2000;19:625–643.

429. Knop E, Knop N. Conjunctiva immune surveillance. In: Dartt DA, Edelhauser HF, ed. Encyclopedia of the Eye. Oxford , UK : Elsevier; 2010.

430. Auw-Haedrich C, Reinhard T. Chronische Blepharitis. Pathogenese, klinischer Verlauf und therapeutische Ansätze. Ophthalmologe . 2007;104:817–828.

431. Knop E, Knop N. Are the Meibomian glands “hair follicles without a hair shaft”? Acta Ophthalmol . 2010;88:246.

432. Choo PH. Distichiasis, trichiasis, and entropion: advances in management. Int Ophthalmol Clin . 2002;42:75–87.

433. Shammas HJ, Tabbara KF, Der K, V. Distichiasis of the lids and lymphedema of the lower extremities: a report of ten cases. J Pediatr Ophthalmol Strabismus. 1979;16:129–132.

434. Fuchs E. The tortoise and the hair: slow-cycling cells in the stem cell race . Cell. 2009;137:811–819.

435. Gupta S, Silliman CG, Trump DL. Docetaxel-induced Meibomian duct inflammation and blockage leading to chalazion formation. Prostate Cancer Prostat Dis . 2007;10:396–397.

436. Paugh JR, Knapp LL, Martinson JR, Hom MM. Meibomian therapy in problematic contact lens wear. Optom Vis Sci. 1990;67:803–806.

437. Kaercher T. Blepharitis. In: Brewitt H, Zierhut M, eds. Trockenes Auge. Heidelberg: Kaden Verlag; 2001:113–126.

438. Shine WE, McCulley JP. Association of meibum oleic acid with meibomian seborrhea . Cornea. 2000;19:72–74.

439. McCulley JP, Shine W. A compositional based model for the tear film lipid layer. Trans Am Ophthalmol Soc. 1997;95:79–88.

440. Gupta AK, Bluhm R. Seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2004;18:13–26.

441. Shine WE, McCulley JP. Meibomian gland triglyceride fatty acid differences in chronic blepharitis patients . Cornea. 1996;15:340–346.

442. Voss JG. Acne vulgaris and free fatty acids: a review and criticism. Arch Dermatol . 1974;109:894–898.

443. Toyoda M, Morohashi M. Pathogenesis of acne. Med Electron Microsc. 2001;34:29–40.

444. Shine WE, McCulley JP. Role of wax ester fatty alcohols in chronic blepharitis. Invest Ophthalmol Vis Sci . 1993;34:3515–3521.

445. Dougherty JM, Osgood JK, McCulley JP. The role of wax and sterol ester fatty acids in chronic blepharitis. Invest Ophthalmol Vis Sci . 1991;32:1932–1937.

446. Shine WE, McCulley JP. Polar lipids in human meibomian gland secretions. Curr Eye Res . 2003;26:89 –94.

447. Kaercher T, Brewitt H. Blepharitis Ophthalmologe . 2004;101: 1135–1147.

448. Suzuki T, Sano Y, Sasaki O, Kinoshita S. Ocular surface inflammation induced by Propionibacterium acnes . Cornea. 2002;21:812–817.

449. Anttila HS, Reitamo S, Saurat JH. Interleukin 1 immunoreactivity in sebaceous glands. Br J Dermatol . 1992;127:585–588.

450. Boehm KD, Yun JK, Strohl KP, Elmets CA. Messenger RNAs for the multifunctional cytokines interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor-alpha are present in adnexal tissues and in dermis of normal human skin. Exp Dermatol. 1995;4:335–341.

451. Guy R, Green MR, Kealey T. Modeling acne in vitro. J Investig Dermatol . 1996;106:176–182.

452. Nagy I, Pivarcsi A, Kis K, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. Microbes Infect. 2006;8:2195–2205.

453. Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M. Keratins and the Keratinocyte Activation Cycle. J Investig Dermatol . 2001;116:633–640.

454. Marren SE. Contact lens wear, use of eye cosmetics, and Meibomian gland dysfunction. Optom Vis Sci. 1994;71:60–62.

455. Molinari JF, Stanek S. Meibomian gland status and prevalence of giant papillary conjunctivitis in contact lens wearers. Optometry . 2000;71:459–461.

456. Robin JB, Nobe JR, Suarez E, Jester JV, Smith RE. Meibomian gland evaluation in patients with extended wear soft contact lens deposits. CLAO J . 1986;12:95–98.

457. Molinari JF. Meibomian stenosis and soft contact lenses (letter). Am J Optom Physiol Opt . 1981;58:690.

458. Ong BL, Larke JR. Meibomian gland dysfunction: some clinical, biochemical and physical observations. Ophthalmic Physiol Opt. 1990;10:144–148